Cerus | CERS - Gross Profit On Sales


Cerus reported $33.33M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Cerus USD 33.33M 8.66M Dec/2024
GRIFOLS EUR 704M 84M Jun/2026
Haemonetics USD 202.8M 4.59M Jun/2026
Neogen USD 99M 7.7M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Quidel USD 223.9M 315.7M Jun/2026
Rockwell Medical USD 4.55M 1.49M Jun/2024
STAAR Surgical USD 69.73M 868K Jun/2026
Terumo JPY 178.54B 29.52B Jun/2026
Utah Medical Products USD 5.8M 450K Sep/2024